Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 5,500 shares at $64.23 ($354K) on 2018-10-09, disclosed to the SEC on 2018-10-11.
Scheduled sale ($354k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.23 | 4,400 | $283K | 79.8% |
| 2 | $64.87 | 1,100 | $71K | 20.2% |
| Total | $64.36 avg | 5,500 | $354K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |